Publications by authors named "Timothy Cote"

Claim this Profile
D
Direct observation of magnetic ordering induced systematic lattice disorder in artificial rhombus spin ices.
Timothy Cote, Amanda K Petford-Long, Charudatta Phatak

Nanoscale· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for worldwide policy and action plans for rare diseases.
John Forman, Domenica Taruscio, Virginia A Llera, Luis A Barrera, Timothy R Coté

Acta Paediatr· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology as a cornerstone of orphan drug development.
Edward D Bashaw, Shiew-Mei Huang, Timothy R Coté, Anne R Pariser, Christine E Garnett

Nat Rev Drug Discov· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
Kui Xu, Timothy R Coté

Brief Bioinform· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials.
Anne R Pariser, Kui Xu, John Milto, Timothy R Coté

Discov Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating orphan drug development.
Timothy R Coté, Kui Xu, Anne R Pariser

Nat Rev Drug Discov· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Orphan Drug Act and the development of stem cell-based products for rare diseases.
Scott N Freeman, Kathryn A Burke, Menfo A Imoisili, Timothy R Coté

Cell Stem Cell· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years.
M Miles Braun, Sheiren Farag-El-Massah, Kui Xu, Timothy R Coté

Nat Rev Drug Discov· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for inborn errors of metabolism: what has the orphan drug act delivered?
Sonali S Talele, Kui Xu, Anne R Pariser, M Miles Braun, Sheiren Farag-El-Massah

Pediatrics· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duchenne muscular dystrophy: Drug development and regulatory considerations.
D Elizabeth McNeil, Carole Davis, Devanand Jillapalli, Shari Targum, Anthony Durmowicz

Muscle Nerve· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan products: an emerging trend in drug approvals.
Timothy Coté, Aditya Kelkar, Kui Xu, M Miles Braun, M Ian Phillips

Nat Rev Drug Discov· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
Timothy R Coté, Leslie H Sobin

Melanoma Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive group-A streptococcal infection in an allograft recipient. A case report.
Ellen H Lee, Dayna Ferguson, Daniel Jernigan, Melissa Greenwald, Timothy Coté

J Bone Joint Surg Am· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model "go-kit" for use at Strategic National Stockpile Points of Dispensing.
Larissa May, Timothy Cote, Bernard Hardeman, Gabriela R Gonzalez, Sherry B Adams

J Public Health Manag Pract· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration.
Jennifer J Wood, Mark A Malek, Frank J Frassica, Jacquelyn A Polder, Aparna K Mohan

J Bone Joint Surg Am· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthrax scare 2005, Washington, DC: operational issues in chemoprophylaxis.
Bernard Hardeman, Thomas Calhoun, Walter Faggett, Gabriela Gonzalez, Gisele Sidbury

Ann Emerg Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
Timothy R Coté, Aparna K Mohan, Jacquelyn A Polder, Marc K Walton, M Miles Braun

J Am Acad Dermatol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissues from population-based cancer registries: a novel approach to increasing research potential.
Marc T Goodman, Brenda Y Hernandez, Stephen Hewitt, Charles F Lynch, Timothy R Coté

Hum Pathol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
Brenda Y Hernandez, Henry F Frierson, Christopher A Moskaluk, Yu Jim Li, Limin Clegg, Timothy R Cote

Hum Pathol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
Aparna K Mohan, Timothy R Coté, Joel A Block, Augustine M Manadan, Jeffrey N Siegel

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Sandra E Brooks, Min Zhan, Timothy Cote, Claudia R Baquet

Gynecol Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deaths among children less than two years of age receiving palivizumab: an analysis of comorbidities.
Aparna K Mohan, M Miles Braun, Susan Ellenberg, Judith Hedje, Timothy R Coté

Pediatr Infect Dis J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Mark E Sherman, Pamela J Mink, Rochelle Curtis, Timothy R Cote, Sandra Brooks

Cancer· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology and classification of ovarian tumors.
Vivien W Chen, Bernardo Ruiz, Jeffrey L Killeen, Timothy R Coté, Xiao Cheng Wu

Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case reports of heart failure after therapy with a tumor necrosis factor antagonist.
Hyon J Kwon, Timothy R Coté, Michael S Cuffe, Judith M Kramer, M Miles Braun

Ann Intern Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis